AR118767A1 - Pirimidinas sustituidas como inhibidores de jak y su uso para el tratamiento de enfermedades inflamatorias o autoinmunes cutáneas - Google Patents

Pirimidinas sustituidas como inhibidores de jak y su uso para el tratamiento de enfermedades inflamatorias o autoinmunes cutáneas

Info

Publication number
AR118767A1
AR118767A1 ARP200101151A ARP200101151A AR118767A1 AR 118767 A1 AR118767 A1 AR 118767A1 AR P200101151 A ARP200101151 A AR P200101151A AR P200101151 A ARP200101151 A AR P200101151A AR 118767 A1 AR118767 A1 AR 118767A1
Authority
AR
Argentina
Prior art keywords
4alkyl
optionally substituted
group
treatment
4alkoxy
Prior art date
Application number
ARP200101151A
Other languages
English (en)
Spanish (es)
Inventor
Jianhua Chao
Philip A Gerken
Original Assignee
Theravance Biopharma R&D Ip Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theravance Biopharma R&D Ip Llc filed Critical Theravance Biopharma R&D Ip Llc
Publication of AR118767A1 publication Critical patent/AR118767A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ARP200101151A 2019-04-24 2020-04-23 Pirimidinas sustituidas como inhibidores de jak y su uso para el tratamiento de enfermedades inflamatorias o autoinmunes cutáneas AR118767A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201962837827P 2019-04-24 2019-04-24

Publications (1)

Publication Number Publication Date
AR118767A1 true AR118767A1 (es) 2021-10-27

Family

ID=70779856

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP200101151A AR118767A1 (es) 2019-04-24 2020-04-23 Pirimidinas sustituidas como inhibidores de jak y su uso para el tratamiento de enfermedades inflamatorias o autoinmunes cutáneas

Country Status (11)

Country Link
US (1) US11439641B2 (cg-RX-API-DMAC7.html)
EP (1) EP3959213B1 (cg-RX-API-DMAC7.html)
JP (1) JP7482152B2 (cg-RX-API-DMAC7.html)
AR (1) AR118767A1 (cg-RX-API-DMAC7.html)
CA (1) CA3135388A1 (cg-RX-API-DMAC7.html)
ES (1) ES2994097T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20241053T1 (cg-RX-API-DMAC7.html)
HU (1) HUE067909T2 (cg-RX-API-DMAC7.html)
PL (1) PL3959213T3 (cg-RX-API-DMAC7.html)
TW (1) TW202106681A (cg-RX-API-DMAC7.html)
WO (1) WO2020219640A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA49956B1 (fr) 2017-10-27 2022-11-30 Theravance Biopharma R&D Ip Llc Composés de pyrimidine utilisés en tant qu'inhibiteurs de kinase jak
CN115925705B (zh) * 2018-11-30 2024-12-31 江苏豪森药业集团有限公司 杂芳类衍生物调节剂、其制备方法和应用
JP7470713B2 (ja) * 2019-04-24 2024-04-18 セラヴァンス バイオファーマ アール&ディー アイピー, エルエルシー Jakキナーゼ阻害剤としてのエステルおよびカルボナートピリミジン化合物
WO2022083687A1 (zh) * 2020-10-21 2022-04-28 南京明德新药研发有限公司 硒杂环类化合物及其应用
WO2022094174A1 (en) * 2020-10-30 2022-05-05 Children's Hospital Medical Center Compositions and methods for the treatment of esophageal conditions
AU2022270072A1 (en) 2021-05-03 2023-11-02 Incyte Corporation Jak1 pathway inhibitors for the treatment of prurigo nodularis
JP2024516299A (ja) * 2021-05-03 2024-04-12 インサイト・コーポレイション 結節性痒疹の治療のためのルキソリチニブ
WO2023202706A1 (zh) * 2022-04-21 2023-10-26 南京明德新药研发有限公司 硒杂环类化合物的盐型和晶型及其应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4919934A (en) 1989-03-02 1990-04-24 Richardson-Vicks Inc. Cosmetic sticks
US6660731B2 (en) 2000-09-15 2003-12-09 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
AU2001290912A1 (en) 2000-09-15 2002-03-26 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
BR0116493A (pt) 2000-12-21 2003-09-30 Vertex Pharma Compostos de pirazol úteis como inibidores de proteìna cinase
ATE508126T1 (de) 2005-11-16 2011-05-15 Vertex Pharma Als kinaseinhibitoren geeignete aminopyrimidine
TW200817391A (en) 2006-06-30 2008-04-16 Astrazeneca Ab Novel compounds
AU2007269540B2 (en) 2006-07-05 2013-06-27 Exelixis, Inc. Methods of using IGF1R and Abl kinase modulators
RU2014129740A (ru) 2011-12-22 2016-02-10 Ф.Хоффманн-Ля Рош Аг Производные 2,4-диаминопиримидина в качестве ингибиторов серин/треонин киназы
WO2015094803A1 (en) 2013-12-16 2015-06-25 Calitor Sciences, Llc Substituted heteroaryl compounds and methods of use
NO2721710T3 (cg-RX-API-DMAC7.html) 2014-08-21 2018-03-31
ES2924698T3 (es) 2015-05-28 2022-10-10 Theravance Biopharma R&D Ip Llc Proceso e intermedios para la preparación de compuestos de naftiridina como inhibidores de quinasa JAK
WO2017189822A1 (en) 2016-04-28 2017-11-02 Theravance Biopharma R&D Ip, Llc Pyrimidine compounds as jak kinase inhibitors
CN106588885B (zh) * 2016-11-10 2019-03-19 浙江大学 2-取代芳环-嘧啶类衍生物及制备和应用
MA49956B1 (fr) 2017-10-27 2022-11-30 Theravance Biopharma R&D Ip Llc Composés de pyrimidine utilisés en tant qu'inhibiteurs de kinase jak
TWI740288B (zh) 2018-11-27 2021-09-21 大陸商江蘇豪森藥業集團有限公司 含氮雜芳類衍生物調節劑、其製備方法和應用
CN115925705B (zh) 2018-11-30 2024-12-31 江苏豪森药业集团有限公司 杂芳类衍生物调节剂、其制备方法和应用
JP7470713B2 (ja) * 2019-04-24 2024-04-18 セラヴァンス バイオファーマ アール&ディー アイピー, エルエルシー Jakキナーゼ阻害剤としてのエステルおよびカルボナートピリミジン化合物
CN113372364B (zh) 2020-03-10 2024-05-31 明慧医药(上海)有限公司 一类jak激酶抑制剂及其制备和应用
CN113372351A (zh) 2020-03-10 2021-09-10 明慧医药(杭州)有限公司 一类jak激酶抑制剂及其制备和应用

Also Published As

Publication number Publication date
EP3959213C0 (en) 2024-06-05
US20200338073A1 (en) 2020-10-29
JP2022529371A (ja) 2022-06-21
CA3135388A1 (en) 2020-10-29
JP7482152B2 (ja) 2024-05-13
US11439641B2 (en) 2022-09-13
EP3959213A1 (en) 2022-03-02
TW202106681A (zh) 2021-02-16
EP3959213B1 (en) 2024-06-05
WO2020219640A1 (en) 2020-10-29
PL3959213T3 (pl) 2024-11-04
HRP20241053T1 (hr) 2024-11-08
ES2994097T3 (en) 2025-01-17
HUE067909T2 (hu) 2024-11-28

Similar Documents

Publication Publication Date Title
AR118768A1 (es) Derivados de pirimidina como inhibidores de las cinasas jak
AR123648A1 (es) Compuestos de carbamoilpiridona tricíclicos puenteados y sus usos
AR090121A1 (es) Compuestos de oxazolidin-2-ona y usos de los mismos
AR108097A1 (es) ANTAGONISTAS SOLUBLES DE C5aR
EA201991399A1 (ru) Аминотриазолопиридиновые соединения и их применение в лечении рака
EA201791727A1 (ru) 7-бензил-4-(2-метилбензил)-2,4,6,7,8,9-гексагидроимидазо[1,2-а]пиридо[3,4-е]пиримидин-5(1н)-он, его аналоги и соли и способы их применения в терапии
AR112834A1 (es) Derivados de rapamicina
AR112098A1 (es) 3-fenilisoxazolin-5-carboxamidas de tetrahidro- y dihidrofurancarboxamida con efecto herbicida
AR119322A1 (es) Compuestos derivados de 1h-pirido[1,2-a]pirazina como inhibidores de magl
AR094790A1 (es) Derivados sustituidos del ácido bisfenil butanóico fosfónico como inhibidores de la nep
CO2017006674A2 (es) Pirazolo[1,5-a]pirazinas 4,6-sustituidas como inhibidores de janus cinasas.
MX392440B (es) Inhibidores de tirosina quinasa de bazo (syk).
AR093532A1 (es) Compuestos y composiciones para el tratamiento de enfermedades parasitarias
MX2016001427A (es) Inhibidores de syk.
MX372934B (es) Compuestos de imidazopiridina y sus usos.
BR112022012684A2 (pt) Compostos cíclicos e métodos de uso dos mesmos
HRP20241053T1 (hr) Pirimidinski inhibitori jak, namijenjeni liječenju kožnih bolesti
MX2018013763A (es) Compuestos para promover crecimiento del cabello y/o inhibir o retardar perdida del cabello en humanos, y composiciones para tales usos.
AR106100A1 (es) Compuestos bicíclicos como inhibidores duales atx / ca
CL2021001656A1 (es) Compuestos de imidazopiridina e imidazopiridina y sus usos.
CL2007001711A1 (es) Compuestos derivados de pirazolopiridina sustituida;composicion farmaceutica que los comprende;metodo de preparacion de los compuestos ,compuestos intermediarios;y su uso en el tratamiento de enfermedades,tales como tumores,artritis reumatoide,enfermedades del crecimiento vascular desregulado, entre otras.
AR087868A1 (es) Compuestos de triazolopiridina como moduladores de la tirosina quinasa c-met
AR092703A1 (es) Peptidos ciclicos y su uso como medicinas
AR120800A1 (es) Derivados de 6,7-dihidro-5h-pirrolo[1,2-c]imidazol como inhibidores de egfr
EA201891710A1 (ru) Терапевтические соединения

Legal Events

Date Code Title Description
FA Abandonment or withdrawal